WHITEWRIGHT, Texas -- The family of a Whitewright veteran diagnosed with cancer is trying to help him get his life back to normal. "I don't have any doubt in my mind that he's going to fight it, but anyone that's dealt with it knows it…
TROPHIES Lafayette College Biology Professor Khadijah Mitchell is involving the Easton area community in her research, seeking to explain why African-Americans have higher incidences of lung cancer than European-Americans. Mitchell and student researchers …
NOVEMBER is reserved each year as a time when we all try to raise awareness about lung diseases. This includes not only lung cancer, but other conditions such as chronic obstructive pulmonary disease. Usually during October there is a lot of buzz …
Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer, said: “We are encouraged to see that Imfinzi monotherapy activity is in-line with that of the anti-PD-1 class in previously-untreated patients with Stage IV non- …
BILLINGS – Lung cancer is difficult to detect, which often meant that it was found too late for patients to be cured. “Historically, lung cancer was one of those cancers that often didn’t have a lot of symptoms until it was too late,” said Dr. Eric Bruen …
Research and Markets Posted on: 16 Nov 18 The "Blockbuster Oncology Brands Market Size, Share & Trends Analysis Report By Brand (Opdivo, Revlimid, Zejula), By Indication (Lung Cancer, Lymphoma, Multiple Myeloma), And Segment Forecasts, 2018 - 2027 …
Lung cancer is a condition that causes cells to divide in the lungs uncontrollably. This causes the growth of tumors that reduce a person's ability to breathe.According to the Centers for Disease Control, 218,527 people in the United States received a …
Hutchison China Meditech Ltd (LON:HCM) had almost £1bn wiped off its value as flagship treatment fruquintinib stumbled in a final stage lung cancer trial. In a study of 527 patients in China, fruquintinib slowed the disease but failed to improve survival …
* AstraZeneca "disappointed" that results missed goal * Key drug Imfinzi a focus for investors * Study looked at treatment of most advanced lung cancer (Adds details, share movement) By Noor Zainab Hussain and Arathy S Nair Nov 16 (Reuters) - …
FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo (Reuters) - AstraZeneca’s (AZN.L) combination of two immunotherapy drugs did not meet the main goal in a closely …
This announcement contains inside information AstraZeneca and MedImmune, its global biologics research and development arm, today announced final overall survival (OS) results for the Phase III MYSTIC trial, a randomised, open-label, multi-centre, global …
StockMarketWire.com - Hutchison China MediTech said Friday its lung cancer treatment did not meet its primary objective after failing to demonstrate a 'statistically significant' increase in overall survival. The results emerged from its phase 3 …
FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo (Reuters) - AstraZeneca’s combination of two immunotherapy drugs did not meet the main goal in a closely watched …
FILE PHOTO: A man walks past a sign at an AstraZeneca site in Macclesfield, central England May 19, 2014. REUTERS/Phil Noble/File Photo (Reuters) - AstraZeneca’s combination of two immunotherapy drugs did not meet the main goal in a closely watched …
– Trial did not meet the primary endpoint of overall survival despite improvement in progression-free survival – LONDON, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces the outcome of …
Nov 15, 2018 7:07 PM EST (CNN) —November is National Lung cancer Awareness month. This is a time for everyone to play a part and make a difference for the hundreds of thousands of people who are diagnosed or die from the disease each year. Here’s Kim …
Merck KGaA MKKGY, +2.36% and Pfizer Inc. PFE, +0.69% said early Monday that the cancer immunotherapy avelumab did not meet the primary endpoints of a phase 3 ovarian cancer trial. The trial, JAVELIN Ovarian 200, tested avelumab both alone and in …
Consultant surgeon Giuseppe Aresu worked with consultant anaesthetists at the hospital to perform the procedure on a patient who had a tumour called thymoma with associated myasthenia gravis, a condition which weakens body muscles. Surgeons normally treat …
CAMBRIDGE, Mass., Nov. 15, 2018 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced updated data for the …
Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.
Track news across more than 5,000 sources by country or industry or search our real-time news index.
News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.
Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.
Have an event? Add it to our Events & Conferences Directory.
This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 10/22/2018
Syndeo Announces New Leadership Additions for Accelerated Growth BELFAST, UNITED_KINGDOM, November 19, 2018 /EINPresswire.com/ -- Digital customer experience technology provider Syndeo today announced several enhancements to the company’s …
For patients who take medication to treat hypothyroidism, being treated with too much medication can lead to increased risk of atrial fibrillation, study finds. SALT LAKE CITY, UT, USA, November 19, 2018 /EINPresswire.com/ -- For patients who …
NEW YORK, NEW YORK, USA, November 19, 2018 /EINPresswire.com/ -- The Louisiana Mesothelioma Victims Center says, "We offering to do everything possible for a person in Louisiana to make certain the receive the very best possible financial …
Glasgow, Scotland, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. (formerly HCi Viocare) (OTCQB:VICA), provides update on recent management changes. Rafina Innovations Inc. was created to be a dynamic technology start-up. …
RADNOR, Pa., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, …
NEW YORK, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, …
TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has been recognized with the 2018 Business Innovation Award by the Mississauga Board of Trade …
SOUTH SAN FRANCISCO, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate Development of Sunesis, will present at …
Planning Phase II Trial VANCOUVER, B.C., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCD) (the “Company” or “Nash Pharma”) is pleased …
Joint venture to distribute endocannabinoid-supporting products to Canadian natural health product stores and pharmacies VICTORIA, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) is …
Positive proof of concept data with Bria-IMT™ Monotherapy will highlight potent anti-tumor activity and an excellent safety profile for Bria-IMT™ in advanced breast cancer. Patient dosing is ongoing in a combination study of Bria-IMT™ with KEYTRUDA® (by …
IRVINE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the conditional acceptance from the U.S. Food and Drug Administration (“FDA”) of the Jeuveau™ brand name for its lead …
All this stress, anxiety, restlessness, sleeplessness, greed, hatred, & the other attributes of our basic animal nature are due to the belief of being the best. WASHINGTON, DC, USA, November 17, 2018 /EINPresswire.com/ -- NO HUMILITY = NO …
PETALUMA, Calif., Nov. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of a “best efforts” public offering of units consisting of one share of common stock, together with one half of one warrant to …
Continues to Build Team with Strategic Hires BOSTON, MA, USA, November 16, 2018 /EINPresswire.com/ -- The team at solo sciences inc. (solo*) continues to gain support for the company’s rapid expansion. Most recently, Chirag Shah has joined the …
SEATTLE , WASHINGTON, USA, November 16, 2018 /EINPresswire.com/ -- Dr. Gregg Jantz, a frequent speaker and gifted author on topics like depression and anxiety, gives audiences a fresh take on defeating their worries in his book Seven Answers for …
FAIRFIELD, CALIFORNIA, UNITED STATES, November 16, 2018 /EINPresswire.com/ -- Janie P. Bess is the author of Visions: A Memoir, in which she recounts her life story and the story of her son David Jr., affectionately known to his friends and …
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or …
BUENA, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarterly period ended …
Last month, the U.S. Department of Agriculture and the U.S. Food and Drug Administration held a public meeting to discuss the use of livestock and poultry cell lines to develop cell-cultured food products. At this meeting, stakeholders shared valuable …
Welcome to EIN Newsdesk
Millions of professionals find us an indispensable source for
breaking news. Basic accounts are FREE.
Sources
We scan thousands of news sites, so you don't have to, saving
you time and money.
Topics
We are similar to Google News but focus on news tracking by country,
industry and topic, so you don't miss any important news
that affects your company, organization or interest.
Custom News
Any news page or search results can be turned into an email news alert
or live RSS feed. You can share relevant news on your website,
intranet, workgroup or mobile device.
News Alert Maker
It's a one-stop destination for all your alerts and feeds.
Manage your media monitoring in one secure location.
Relevant. Time-Saving. Free.
And so easy to use. Check out our short video and
check in with us to start right now.
Get Started
Join millions of professionals in business, industry, and government who
have relied on EIN News since 1995.
